Design of bile-based vesicles (BBVs) for hepatocytes specific delivery of Daclatasvir: Comparison of ex-vivo transenterocytic transport, in-vitro protein adsorption resistance and HepG2 cellular uptake of charged and β-sitosterol decorated vesicles.

MLA

Boseila, Amira A., et al. “Design of Bile-Based Vesicles (BBVs) for Hepatocytes Specific Delivery of Daclatasvir: Comparison of Ex-Vivo Transenterocytic Transport, in-Vitro Protein Adsorption Resistance and HepG2 Cellular Uptake of Charged and β-Sitosterol Decorated Vesicles.” PloS One, vol. 14, no. 7, July 2019, p. e0219752. EBSCOhost, https://doi.org/10.1371/journal.pone.0219752.

APA

Boseila, A. A., Abdel-Reheem, A. Y., & Basalious, E. B. (2019). Design of bile-based vesicles (BBVs) for hepatocytes specific delivery of Daclatasvir: Comparison of ex-vivo transenterocytic transport, in-vitro protein adsorption resistance and HepG2 cellular uptake of charged and β-sitosterol decorated vesicles. PloS One, 14(7), e0219752. https://doi.org/10.1371/journal.pone.0219752

Chicago

Boseila, Amira A, Amal Y Abdel-Reheem, and Emad B Basalious. 2019. “Design of Bile-Based Vesicles (BBVs) for Hepatocytes Specific Delivery of Daclatasvir: Comparison of Ex-Vivo Transenterocytic Transport, in-Vitro Protein Adsorption Resistance and HepG2 Cellular Uptake of Charged and β-Sitosterol Decorated Vesicles.” PloS One 14 (7): e0219752. doi:10.1371/journal.pone.0219752.